October 26, 2018
3 min watch

VIDEO: Eyenovia's microdosing technology promising for treating progressive myopia

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the Ophthalmology Innovation Summit at the American Academy of Ophthalmology meeting, Sean Ianchulev, MD, MPH, president and CEO of Eyenovia,discusses the company’s microdosing technology for the treatment of progressive myopia.